653 papers
Microbiology explores the invisible world of tiny life forms that shape our health, environment, and even the air we breathe. From bacteria and viruses to fungi and parasites, this field investigates how these microscopic organisms interact with us and each other, driving everything from disease outbreaks to beneficial fermentation processes. Understanding them is crucial for developing new medicines, improving food safety, and combating global health challenges.
At Gist.Science, we make the latest discoveries in this dynamic field accessible to everyone. We process every new preprint uploaded to bioRxiv in this category, transforming dense academic findings into both clear, plain-language explanations and detailed technical summaries. This ensures that whether you are a student, a researcher, or simply curious, you can grasp the significance of cutting-edge science without getting lost in jargon.
Below are the most recent papers in microbiology, curated and summarized directly from the bioRxiv server to keep you at the forefront of discovery.
The compact type III-A Druantia defense system in bacteria clears phage infections by utilizing the DruE helicase to recognize exposed single-stranded DNA and unwind it in a 3'-to-5' direction, a process regulated by the dissociation of the DruH protein upon infection.
The authors developed CandiChrome, a versatile seven-fluorophore toolkit that enables the simultaneous tracking of up to 21 distinct *Candida albicans* populations in both in vitro and in vivo murine infection models, addressing a critical gap in multicolor imaging tools for this pathogenic fungus.
This study reveals significant strain-specific heterogeneity in *Fusobacterium nucleatum* virulence and indole production among clinical isolates, demonstrating that indole derivatives can differentially inhibit biofilm formation and cancer cell invasion while offering a potential pathway for precision therapeutic targeting of pathogenic strains without harming beneficial commensals.
Researchers discovered potent, orally bioavailable, non-covalent inhibitors of the Zika virus NS2B-NS3 protease through a fragment-based drug design approach, demonstrating significant efficacy in reducing viral loads in a murine infection model.
This study demonstrates that a three-phage combination effectively reduces actively replicating *Mycobacterium tuberculosis* loads and prevents regrowth in planktonic cultures, but exhibits limited antimycobacterial activity against non-replicating bacteria found in disease-relevant hypoxic and acidic conditions, highlighting the necessity of bacterial replication for phage lytic efficacy.
This study demonstrates that a specific human histone H1.2 peptide fragment exhibits potent, non-toxic antibacterial activity against *Pseudomonas aeruginosa* by disrupting outer membrane protein biogenesis and forming NET-like structures, suggesting its potential as a novel therapeutic agent against antimicrobial resistance.
This study demonstrates that host metabolic state significantly influences viral commitment to infection by modulating phage adsorption rates, supporting a two-step model where energy-limited conditions allow bound phages to disengage and avoid non-productive infections.
This study characterizes the unique SAR endolysin-holin system of bacteriophage N4, demonstrating that despite lacking conservation with the T4 lysis mechanism, N4 employs a distinct regulatory strategy to control lysis timing and maximize progeny yield through lysis inhibition.
This study reveals that the transcriptional regulator IscR enables *Acinetobacter baumannii* to survive oxidative stress and antibiotic treatment by upregulating *pbp1a* to induce a rod-to-coccoid morphological shift, which reduces cell surface area and limits the uptake of harmful stress molecules.
This study characterizes the urinary DNA virome of hematopoietic stem cell transplant recipients and healthy Mauritian cynomolgus macaques, identifying three host-specific polyomaviruses that exhibit significantly higher shedding loads in transplant recipients and are associated with urologic disease.